Literature DB >> 25876068

Sleep-disordered breathing and idiopathic pulmonary fibrosis--is there an association?

T Reid1, M Vennelle, M McKinley, P A MacFarlane, N Hirani, A J Simpson, Renata L Riha.   

Abstract

BACKGROUND: Very little data exists on the prevalence and impact of sleep-disordered breathing (SDB) in patients with idiopathic pulmonary fibrosis (IPF). The aim of this study was to examine the impact of SDB on newly diagnosed IPF patients and explore associations with lung function parameters.
METHODS: From 2005 to 2009, a cohort of 27 newly diagnosed patients with IPF underwent unattended polygraphy. All patients were diagnosed according to ATS 2000 diagnostic criteria and were not on supplemental oxygen or other treatment. Standard statistical analysis was undertaken using SPSS v. 19 (IBM).
RESULTS: Of the 27 patients, 19 were men. There was no correlation at baseline of apnoea + hypopnoea per time in bed (AH), oxygen desaturation index, or 4% desaturations with any lung function variables, age, or body mass index. Six patients had significant SDB (AH >20). Two patients were started on CPAP following polygraphy. No variables from the original sleep studies at baseline predicted eventual long-term oxygen therapy (LTOT) use. At 5-year follow-up, 18 of 27 patients had died (67%). Cox regression analysis showed no association of time spent at SpO2 <90% on baseline polygraphy with survival (p = 0.39). There was no association with survival for AH >20 (p = 0.4) or LTOT use (p = 0.19).
CONCLUSION: Our results do not support the contention that nocturnal upper airway obstruction in steroid-free patients with IPF is a common problem or correlated with lung function. In this cohort of patients, there was no evidence that significant SDB at baseline was a predictor of survival.

Entities:  

Mesh:

Year:  2015        PMID: 25876068     DOI: 10.1007/s11325-014-1117-3

Source DB:  PubMed          Journal:  Sleep Breath        ISSN: 1520-9512            Impact factor:   2.816


  5 in total

Review 1.  American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS).

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2000-02       Impact factor: 21.405

2.  Preliminary prospective explanatory observation on the impact of 3-month steroid therapy on the objective measures of sleep-disordered breathing.

Authors:  Gidon Berger; Emilia Hardak; Beatrice Shaham; Emili Avitan; Mordechai Yigla
Journal:  Sleep Breath       Date:  2011-07-14       Impact factor: 2.816

3.  Obstructive sleep apnea is common in idiopathic pulmonary fibrosis.

Authors:  Lisa H Lancaster; Wendi R Mason; James A Parnell; Todd W Rice; James E Loyd; Aaron P Milstone; Harold R Collard; Beth A Malow
Journal:  Chest       Date:  2009-06-30       Impact factor: 9.410

4.  Evaluation of a portable device for diagnosing the sleep apnoea/hypopnoea syndrome.

Authors:  K Dingli; E L Coleman; M Vennelle; S P Finch; P K Wraith; T W Mackay; N J Douglas
Journal:  Eur Respir J       Date:  2003-02       Impact factor: 16.671

5.  Recommendations on treatment for IPF.

Authors:  Jürgen Behr; Luca Richeldi
Journal:  Respir Res       Date:  2013-04-16
  5 in total
  4 in total

1.  The prevalence of obstructive sleep apnea in interstitial lung disease: a systematic review and meta-analysis.

Authors:  Yang Cheng; Yan Wang; Li Dai
Journal:  Sleep Breath       Date:  2021-01-06       Impact factor: 2.816

2.  First Description of the Hyperpnea-Hypopnea Periodic Breathing in Patients with Interstitial Lung Disease-Obstructive Sleep Apnea: Treatment Implications in a Real-Life Setting.

Authors:  Angelo Canora; Carmine Nicoletta; Giacomo Ghinassi; Dario Bruzzese; Gaetano Rea; Annalisa Capaccio; Sabrina Castaldo; Antonietta Coppola; Giorgio Emanuele Polistina; Alessandro Sanduzzi; Marialuisa Bocchino
Journal:  Int J Environ Res Public Health       Date:  2019-11-26       Impact factor: 3.390

Review 3.  Mortality and survival in idiopathic pulmonary fibrosis: a systematic review and meta-analysis.

Authors:  Qiang Zheng; Ingrid A Cox; Julie A Campbell; Qing Xia; Petr Otahal; Barbara de Graaff; Tamera J Corte; Alan K Y Teoh; E Haydn Walters; Andrew J Palmer
Journal:  ERJ Open Res       Date:  2022-03-14

Review 4.  The Association between Idiopathic Pulmonary Fibrosis and Obstructive Sleep Apnea: A Systematic Review and Meta-Analysis.

Authors:  Filip Franciszek Karuga; Piotr Kaczmarski; Bartosz Szmyd; Piotr Białasiewicz; Marcin Sochal; Agata Gabryelska
Journal:  J Clin Med       Date:  2022-08-26       Impact factor: 4.964

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.